Court
According to the lawsuit, Teva paid illegal payments of more than $ 300 million to two charities in 2006-2015, to cover deductibles in the...
Hi, what are you looking for?
Jewish Business News
All posts tagged "Copaxone"
Life science
Teva shares rose 6% at the end of trading in New York after Berkshire Hathaway, the investment company controlled by Warren Buffett, revealed...
Court
The UK court ruled in favor of Mylan and its Dutch partner Synthon and canceled all of Teva's patents on Copaxone 40 mg in...
Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that the the Japanese Ministry of Health, Labour and Welfare has approved once-daily...
Business
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”
Business
Teva says it will seek ‘further appellate review’
Business
Teva’s American Depositary Receipts rose 2.2 percent to $63.31, giving it a market value of just under $54 billion.
Business
Copaxone’s patent remains in force at least until the Federal Circuit Appeals Court reconsiders the case. The rivals of Teva Pharmaceutical Industries Ltd. (NYSE:...
Business
Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE:...
Court
The ruling means Teva’s flagship multiple sclerosis treatment’s patent remains valid until September 2015. The US Supreme Court has ruled in favor of...